Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J2H-1702 in Non-alcoholic Steatohepatitis
NCT06297434Phase 2Completed
- Sponsor
- J2H Biotech
- Start
- Feb 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of J2H-1702 in Nonalcoholic steatohepatitis (NASH), sponsored by J2H Biotech. Started Feb 2023; status: completed.
02
Drugs
J2H-1702
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT06297434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06297434.